Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.